Scabies Treatment Options: Understanding Lotions, Creams, and Oral Medicines

Scabies treatment options include prescription creams, lotions or suspensions applied to the skin, and in some situations an oral antiparasitic medicine. The right choice depends on whether the infestation is classic or crusted scabies, the person's age, pregnancy status, ability to apply a whole-body treatment correctly, medication interactions, and previous treatment response.

In the United States, permethrin 5% cream remains a major first-line topical treatment and is FDA approved for scabies in people at least 2 months old. Oral ivermectin is also used for scabies and is included in CDC treatment guidance, but its use for scabies is not FDA approved. Spinosad 0.9% topical suspension is another FDA-approved option for patients 4 years and older.

Medication is only part of successful treatment. Household members and close contacts often need treatment at the same time, and recently used clothing, bedding, and towels need appropriate cleaning or isolation to reduce reinfestation.

• •What Scabies Treatment Needs to Accomplish
• •Scabies Treatment Options: Creams, Lotions, and Oral Medicines
• •Permethrin Cream for Scabies
• •Oral Ivermectin for Scabies
• •Other Topical Scabies Treatments
• •Why Scabies Treatment Sometimes Appears to Fail
• •Treating Household Contacts and the Home Environment
• •Special Treatment Situations: Children, Pregnancy, and Crusted Scabies
• •Safety and When to Seek Medical Care
• •Conclusion
• •Frequently Asked Questions

What Scabies Treatment Needs to Accomplish

Scabies is caused by the human itch mite Sarcoptes scabiei var. hominis. The mites burrow into the upper layer of skin, where they live and lay eggs. Typical symptoms include intense itching, often worse at night, and a pimple-like rash; small burrows may sometimes be visible.

A true scabies treatment needs to kill the mites. Medicines designed for this purpose are called scabicides. CDC states that no nonprescription or over-the-counter product has been tested and approved to treat human scabies in the United States.

That distinction matters because anti-itch lotions, moisturizers, antihistamines, or topical anti-inflammatory products may make a person more comfortable, but symptom relief is not the same as eliminating the infestation.

A separate scabies symptoms and diagnosis guide can help readers understand how scabies differs from eczema, contact dermatitis, insect bites, folliculitis, and other itchy rashes.

The best scabies treatment is not simply the strongest medicine; success depends on choosing an appropriate scabicide, applying or taking it correctly, and preventing untreated contacts from reintroducing the mites.

Scabies Treatment Options: Creams, Lotions, and Oral Medicines

The physical form of a medicine—cream, lotion, suspension, ointment, or tablet—does not by itself tell you how effective or appropriate it is. The active ingredient, FDA status, patient population, and clinical situation matter more.

Common U.S. scabies treatment options

Treatment	Form	U.S. scabies status	Main role or limitation
Permethrin 5%	Cream	FDA approved for age 2 months+	Major first-line topical option; full-body application is important
Ivermectin	Oral tablet	Not FDA approved for scabies	Useful alternative; safety not established in pregnancy or children under 15 kg
Spinosad 0.9%	Topical suspension	FDA approved for age 4 years+	Alternative topical option; clinical evidence is more limited than for established first-line therapy
Crotamiton 10%	Cream or lotion	FDA approved for adults	Alternative option; frequent treatment failure has been reported
Sulfur 5%–10%	Compounded ointment	Compounded in U.S.	Can be used in children including very young infants; odor can reduce acceptability

The regulatory and age information above reflects current CDC and DailyMed/FDA-linked labeling.

Choosing between topical and oral treatment also involves practical questions. Can the medicine be applied to every required skin area? Is the patient able to follow a repeat-treatment schedule? Are there pregnancy, age, weight, or interaction concerns? Is this ordinary classic scabies or highly contagious crusted scabies?

Permethrin Cream for Scabies

Permethrin 5% cream is FDA approved for treatment of scabies in people at least 2 months old. CDC describes it as a first-line medication for classic scabies.

For most adults with classic scabies, CDC instructions involve applying the cream thoroughly over the required body surface and leaving it on for the prescribed period before washing it off. A second application about a week later may be needed because complete eradication can require more than one treatment.

Readers should follow the prescription and product instructions rather than applying the medicine only to visible spots. Scabies mites may be present in areas where the rash is subtle, and incomplete application is one recognized reason treatment can appear to fail.

What does newer evidence say about permethrin versus ivermectin?

CDC's clinical-care page states that topical permethrin and oral ivermectin have historically shown similar efficacy for cure of scabies. However, evidence continues to evolve.

A large 2026 cluster-randomized clinical trial compared repeated oral ivermectin with repeated 5% permethrin among people with classic scabies and their household contacts. Clinical cure at the household-cluster level was higher with permethrin—88.5% versus 71.8% with ivermectin—and the investigators concluded that ivermectin did not meet the noninferiority criterion and that permethrin was statistically superior in that study.

That result does not prove that oral ivermectin is ineffective or that permethrin will always be superior in every population.

It does reinforce why current treatment decisions should consider updated evidence, correct application, patient characteristics, and clinical circumstances rather than assuming the two options are interchangeable in every case.

Oral Ivermectin for Scabies

Oral ivermectin offers an important alternative when applying cream over the entire body is difficult or when a clinician believes oral therapy is better suited to the situation. CDC includes oral ivermectin as a first-line option for classic scabies in its clinical-care guidance, although ivermectin tablets are not FDA approved specifically for scabies.

Treatment is weight based and generally requires more than one dose because ivermectin has limited activity against mite eggs. The exact regimen should come from the prescribing clinician rather than being calculated from online information.

When oral treatment can be attractive

Oral medicine avoids the challenge of coating large areas of skin with cream. That can be useful when mobility, extensive skin involvement, caregiver limitations, institutional outbreaks, or adherence to topical treatment makes application difficult. CDC also uses oral ivermectin as part of combination treatment for crusted scabies.

However, convenience does not make oral ivermectin appropriate for everyone. CDC states that its safety has not been established in pregnant women or children weighing less than 15 kg. Drug interactions and other health considerations can also influence whether it is selected.

The CDC clinical care guidance for scabies  is the most useful U.S. reference for clinicians and patients who want to see how permethrin, ivermectin, and alternative medicines are categorized.

Other Topical Scabies Treatments

Permethrin is not the only topical scabicide used in the United States.

Spinosad topical suspension

Spinosad 0.9% topical suspension is FDA approved for scabies infestations in adults and children 4 years and older.

Current labeling describes whole-body topical treatment and notes application-site irritation, pain or burning, and dry skin among the more common adverse reactions reported in scabies trials.

The approval was supported by two randomized controlled trials involving adults and children. CDC nevertheless notes that efficacy evidence remains more limited than for the older first-line treatments.

Crotamiton cream or lotion

Crotamiton 10% cream and lotion are FDA approved for scabies in adults, but CDC considers crotamiton an alternative treatment and notes that frequent treatment failure has been reported. It is not FDA approved for children.

That makes it an option a clinician might consider when first-line therapies are unsuitable rather than an obvious replacement for permethrin.

Sulfur ointment

Sulfur ointment in a 5%–10% concentration can be compounded in the United States. CDC notes that sulfur in a petrolatum base is safe for topical use in children, including infants younger than 2 months, making it useful in a population with fewer medication options.

Its main practical drawback is acceptability: sulfur preparations can have an unpleasant odor and require careful application.

What about malathion and lindane?

CDC lists malathion 0.5% lotion as an alternative that is not FDA approved for scabies and notes that published efficacy data are limited.

Lindane has historical FDA approval for scabies but is not recommended as first-line treatment and is currently unavailable in the United States according to CDC. Misuse can cause neurological toxicity, and there are important contraindications involving pregnancy, breastfeeding, young age, low body weight, seizure disorders, irritated skin, and crusted scabies.

Why Scabies Treatment Sometimes Appears to Fail

Not every itchy day after treatment means the mites survived.

CDC explains that scabies itching results from a hypersensitivity reaction to mites and their waste. That immune reaction can continue for several weeks even after successful treatment has killed the infestation.

A 2024 systematic review covering 147 studies estimated an overall treatment-failure prevalence of about 15%, although rates varied widely between studies and regions. Treatment failure can have several explanations, including incorrect application, reinfestation from an untreated contact, an inadequate treatment course, diagnostic error, and potentially reduced susceptibility to a treatment.

Signs that deserve reassessment

CDC advises considering reevaluation or retreatment when itching continues for two to four weeks after treatment or when new burrows or new pimple-like lesions appear.

Persistent itch without new lesions may instead represent post-scabies hypersensitivity. Repeating scabicides unnecessarily can further irritate the skin, so distinguishing persistent inflammation from active infestation is useful.

A clinician may also reconsider whether the original rash was actually scabies if treatment repeatedly fails.

Treating Household Contacts and the Home Environment

Treating one person's skin while ignoring close contacts can create a cycle of reinfestation.

CDC recommends treating household members and close contacts at the same time as the person with scabies. This matters because a newly infested person can transmit mites before symptoms appear; first-time infestations may remain symptom-free for four to eight weeks.

A dedicated scabies household prevention guide can help families coordinate treatment, laundry, contact notification, and return-to-school or work questions.

What needs washing?

CDC recommends washing clothing, bedding, and towels used next to the skin during the three days before treatment in hot water and drying them on a hot cycle. Temperatures above 50°C or 122°F for 10 minutes kill mites and eggs.

Items that cannot be washed or dry-cleaned can be sealed in a closed plastic bag for several days to one week. Scabies mites generally survive only two to three days away from human skin.

The CDC scabies treatment and prevention steps  provide current U.S. instructions for laundry, non-washable items, contact avoidance, and follow-up.

What does not help?

CDC advises against using insecticide sprays or fumigants to treat a home for scabies. Routine laundering and isolation of appropriate personal items are sufficient; environmental pesticide treatment is not recommended.

Special Treatment Situations: Children, Pregnancy, and Crusted Scabies

Certain groups require more careful selection of treatment because evidence and regulatory approvals differ.

Infants and young children

Permethrin 5% is FDA approved for children at least 2 months old. For infants younger than 2 months, CDC identifies sulfur ointment as a topical option and states that only permethrin or sulfur ointment should be used in infants under appropriate medical guidance.

Application areas can also differ in young children. CDC advises that prescribed topical scabicide in children may need to cover the head and neck as well as the body because scabies distribution differs from that in many adults.

Pregnancy and breastfeeding

CDC's STI guidance identifies permethrin as the preferred scabies treatment during pregnancy and lactation because data for ivermectin are more limited. Its current clinical-care page states that ivermectin safety in pregnancy has not been established.

Pregnant or breastfeeding patients should therefore have treatment selected by an obstetric or other qualified clinician rather than using leftover medication from another household member.

Crusted scabies

Crusted scabies is a severe, highly contagious form associated with a much greater mite burden. It is more likely in people who are immunocompromised, debilitated, malnourished, or receiving certain immunosuppressive treatments.

CDC recommends combination treatment with oral ivermectin and a topical agent such as permethrin for crusted scabies rather than relying on one medication alone. Treatment schedules are substantially more intensive and there is no single universally agreed optimal regimen.

A separate crusted scabies guide  would be appropriate for immunocompromised patients, caregivers, nursing facilities, and outbreak-management teams because ordinary classic-scabies instructions are not sufficient.

Safety and When to Seek Medical Care

Scabies should be medically evaluated because other skin disorders can resemble it and U.S. scabicides require prescription treatment. CDC specifically advises people who suspect scabies to seek healthcare evaluation rather than relying on over-the-counter products.

Contact a healthcare professional promptly if skin becomes increasingly painful, hot, swollen, draining, or develops sores suggesting secondary bacterial infection. Scratching can damage the skin, and CDC recommends immediate medical contact if sores develop or infection is suspected.

Reassessment is also appropriate if new burrows or new scabies-like lesions continue to appear after treatment, if itching remains significant beyond the expected post-treatment period, or if several household members remain symptomatic despite coordinated treatment.

Crusted or widespread scaling, particularly in someone who is immunocompromised or medically frail, requires prompt clinical attention because crusted scabies is unusually contagious and requires more intensive combination therapy.

Conclusion

Current scabies treatment options range from permethrin cream and spinosad suspension to alternative topical agents and oral ivermectin. In the United States, permethrin 5% is FDA approved from 2 months of age and remains a major first-line treatment. Oral ivermectin is an important clinician-prescribed alternative but is used off-label for scabies and has additional pregnancy and pediatric limitations.

Newer evidence also reminds us that treatment comparisons can change. A 2026 randomized trial found better clinical cure with repeated permethrin than repeated oral ivermectin in the classic-scabies population studied, even though earlier evidence led CDC to describe the two approaches as having similar efficacy.

Whichever medicine is chosen, successful treatment requires more than treating the rash. Correct application or dosing, treatment of household members and close contacts, appropriate handling of recently used fabrics, and follow-up when new lesions persist are all central to preventing the cycle from starting again.

Frequently Asked Questions

1. What is usually the first treatment for scabies?

Permethrin 5% cream is a major first-line treatment for classic scabies in current U.S. CDC guidance. It is FDA approved for people 2 months of age and older. The best option can still change with age, pregnancy, treatment history, practical application issues, and whether crusted scabies is present.

2. Is oral ivermectin better than permethrin cream for scabies?

Oral ivermectin is an effective scabies treatment, but it is not clearly better than permethrin. CDC historically described the two as having similar cure efficacy, while a 2026 randomized trial found higher cure rates with permethrin in the classic-scabies population studied. Treatment choice should therefore consider both evidence and individual clinical circumstances.

3. Can I buy an over-the-counter lotion that kills scabies?

No U.S. nonprescription product has been tested and approved to eradicate human scabies, according to CDC. Over-the-counter moisturizers or anti-itch products may sometimes reduce discomfort but do not replace a prescribed scabicide. If scabies is suspected, CDC advises seeking medical evaluation.

4. Why am I still itching after scabies treatment?

Itching can continue for several weeks even after treatment has killed the mites because the immune reaction to mite material does not disappear immediately. New burrows, new pimple-like lesions, or itching that remains beyond roughly two to four weeks should prompt reassessment. Persistent itching alone does not prove that treatment failed.

5. Does everyone in the household need scabies treatment?

CDC recommends treating household members and close contacts at the same time to reduce reinfestation. A person can transmit scabies before symptoms appear, which is why waiting for every household member to start itching can miss an infestation. The healthcare professional should advise exactly which contacts require treatment.

6. Can pregnant women take ivermectin for scabies?

Permethrin is the preferred scabies treatment during pregnancy in CDC guidance because pregnancy data for ivermectin remain limited. CDC states that the safety of oral ivermectin in pregnant women has not been established. Pregnant or breastfeeding patients should have treatment selected by a qualified healthcare professional.